Envoy Medical Inc. (NASDAQ: COCH) completed enrollment of 56 patients in its pivotal clinical trial for the Acclaim cochlear implant ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE